Penatmidine prevented pneumocystosis among pediatric HSCT patients

May 2013
Infectious Disease News;May2013, Vol. 26 Issue 5, p28
The article discusses research which revealed that intravenous pentamidine is safe and effective for the prevention of Pneumocystis carinii pneumonia in pediatric hematopoietic stem cell transplantation patients, published in a 2013 issue of the "Pediatric Infectious Diseases Journal."


Related Articles

  • Pneumocystis carinii pneumonia.  // MMWR: Morbidity & Mortality Weekly Report;6/27/1997 Supplement RR-12, Vol. 46, p4 

    Provides information on the disease pneumocystis carinii pneumonia. Recommendation made by authorities relating to the prevention of exposure to disease; Precautions that should be considered by adolescents, adults and pregnant women.

  • Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients. Torres, H.; Chemaly, R.; Storey, R.; Aguilera, E.; Nogueras, G.; Safdar, A.; Rolston, K.; Raad, I.; Kontoyiannis, D. // European Journal of Clinical Microbiology & Infectious Diseases;Jun2006, Vol. 25 Issue 6, p382 

    Pneumocystis jiroveci pneumonia is a common infection in patients with AIDS but an infrequent cause of pneumonia in cancer patients. Little is known about the impact of cancer type and hematopoietic stem cell transplantation on the presentation and outcome of P. jiroveci pneumonia in cancer...

  • Pentamidine Oral Inhalation.  // AHFS Consumer Medication Information;Feb2020, p1 

    Pentamidine is an anti-infective agent that helps to treat or prevent pneumonia caused by the organism Pneumocystis carinii. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

  • Pentamidine prevented pneumocystosis among pediatric HSCT patients.  // Hem/Onc Today;5/25/2013, Vol. 14 Issue 10, p8 

    The article discusses the findings of a retrospective study which revealed the safety and efficacy of using intravenous pentamidine for the prevention of Pneumocystis carinii pneumonia in pediatric patients who underwent hematopoietic stem cell transplantation.

  • DELAYING THE ONSET OF ILLNESS. Cohan, Gary R. // Advocate;2/8/94, Issue 648, p34 

    Reports that prophylaxis against Pneumocystis carinnii infection may delay the onset of the first AIDS-related illness.

  • Prophylaxis Failure Is Associated with a Specific Pneumocystis carinii Genotype. Hauser, Philippe M.; Sudre, Philippe; Nahimana, Aimable; Francioli, Patrick // Clinical Infectious Diseases;10/1/2001, Vol. 33 Issue 7, p1080 

    To investigate the possible association between Pneumocystis carinii types and various clinical and demographic parameters, we used molecular typing to analyze 93 bronchoalveolar lavage specimens from patients with P. carinii pneumonia (PCP). Multivariate regression analysis revealed an...

  • PCP prophylaxis with use of corticosteroids by neurologists. Kelly, Dearbhla M.; Cronin, Simon // Practical Neurology (BMJ Publishing Group);Apr2014, Vol. 14 Issue 2, p74 

    Pneumocystis jirovecii pneumonia (PCP) is increasingly reported in patients without HIV. Corticosteroids are a major risk factor, with up to 90% of patients receiving corticosteroid treatment prior to the development of PCP. In view of this, many specialties now prescribe PCP prophylaxis to...

  • Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis. Jiang, Xuqin; Mei, Xiaodong; Feng, Di; Wang, Xiaojing // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Pneumocystis jiroveci pneumonia (PCP) is frequently reported in lymphoma patients treated with rituximab-contained regimens. There is a trend toward a difference in PCP risk between bi- and tri-weekly regimens. The aims of this systemic review and meta-analysis were to estimate the risk for PCP...

  • Antimicrobial stewardship efforts to manage a pentamidine shortage. Paskovaty, Alla; Lucarelli, Charles D.; Patel, Priti; Ryan, Marie; Seyboth, Brian; Thackray, Jennifer; Pozotrigo, Melissa; Orsini, Nina; Seo, Susan K. // American Journal of Health-System Pharmacy;12/1/2014, Vol. 71 Issue 23, p2014 

    The article discusses how the antimocrobial stewardship programs (ASPs) at Memorial Sloan Kettering Cancer Center coordinated with the pharmacy department, clinical oncology pharmacy specialists and hematologic and bone marrow transplantation (BMT) services during a critical pentamidine...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics